S100A9 and cancer: Notably, while methylation, mRNA, protein, and phosphorylated protein levels of S100A9 did not show significant differences across cancer stages in patients with colon adenocarcinoma (COAD), all stages exhibited significant differences compared to those in normal tissues (Figure 6A).